These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 15973594

  • 1. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D.
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [Abstract] [Full Text] [Related]

  • 3. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW.
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 5. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK, Hong SS, Choi YJ, Park SH, Ahn H, Kim CS, Cho KS.
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [Abstract] [Full Text] [Related]

  • 6. Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium.
    Carreira GC, Gemeinhardt O, Beyersdorff D, Schnorr J, Taupitz M, Lüdemann L.
    Magn Reson Imaging; 2009 Apr; 27(3):360-9. PubMed ID: 18768279
    [Abstract] [Full Text] [Related]

  • 7. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
    Wu X, Wang H, Chen F, Jin L, Li J, Feng Y, DeKeyzer F, Yu J, Marchal G, Ni Y.
    Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
    [Abstract] [Full Text] [Related]

  • 8. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [Abstract] [Full Text] [Related]

  • 9. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R, Curcic J, Remmele S, Altomonte J, Ebert O, Rummeny EJ, Steingoetter A.
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [Abstract] [Full Text] [Related]

  • 10. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
    Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K.
    J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].
    Franiel T, Lüdemann L, Taupitz M, Rost J, Asbach P, Beyersdorff D.
    Rofo; 2009 Jun; 181(6):536-42. PubMed ID: 19353483
    [Abstract] [Full Text] [Related]

  • 12. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
    Cornud F, Beuvon F, Thévenin F, Chauveinc L, Vieillefond A, Descazeaux A, Flam T.
    Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
    [Abstract] [Full Text] [Related]

  • 13. [Detection of prostate carcinomas with T1-weighted dynamic contrast-enhanced MRI. Value of two-compartment model].
    Kiessling F, Lichy M, Grobholz R, Farhan N, Heilmann M, Michel MS, Trojan L, Werner A, Rabe J, Delorme S, Kauczor HU, Schlemmer HP.
    Radiologe; 2003 Jun; 43(6):474-80. PubMed ID: 12827262
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
    Hohl C, Haage P, Krombach GA, Schmidt T, Ahaus M, Günther RW, Staatz G.
    Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
    [Abstract] [Full Text] [Related]

  • 15. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 16. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M.
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [Abstract] [Full Text] [Related]

  • 17. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH, Mamisch TC, Hughes T, Zilkens C, Quirbach S, Scheffler K, Kraff O, Schweitzer ME, Szomolanyi P, Trattnig S.
    Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
    [Abstract] [Full Text] [Related]

  • 18. Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner.
    Sadick M, Schock D, Kraenzlin B, Gretz N, Schoenberg SO, Michaely HJ.
    Invest Radiol; 2009 Aug; 44(8):469-75. PubMed ID: 19465861
    [Abstract] [Full Text] [Related]

  • 19. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S, Baghi M, Wagenblast J, Bisdas T, Thng CH, Mack MG, Koh TS, Ernemann U.
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [Abstract] [Full Text] [Related]

  • 20. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE, Hutchinson CE, Buckley DL.
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.